|
WO2020071818A1
|
|
Catalyst for asymmetric hydrogenation of compound containing carbon double bond
|
|
KR20200038182A
|
|
Catalyst for asymmetric hydrogenation of compound having carbon double bond
|
|
KR20210014521A
|
|
Synthesizing Method Of 2-((6-(hydroxymethyl)chromene-5-yl)oxy)-1-phenylethanone Derivative
|
|
WO2019194583A1
|
|
3-phenyl-2,8-dihydropyrano[2,3-f]chromene derivative and pharmaceutical composition comprising same
|
|
TW202003523A
|
|
METHOD FOR SYNTHESIZING 3-PHENYL-2,8-DIHYDROPYRANO[2,3-ƒ]CHROMENE DERIVATIVES
|
|
KR20200105198A
|
|
Pharmaceutical composition for the prevention or treatment of neurological diseases
|
|
US2020048272A1
|
|
Method for synthesizing 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2.3-f]chromene derivative and optical isomer of thereof
|
|
AU2017287746A1
|
|
Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
|
|
KR20180094714A
|
|
6,7-disubstituted 3-(2-hydroxyphenyl)chroman derivatives and pharmaceutical composition for treating metabolic syndrome or inflammatory disease
|
